Pricing Log in Create free account

EyePoint, Inc. (EYPT) vs Promis Neurosciences (PMN)

EyePoint, Inc. and Promis Neurosciences are both Biotechnology companies. EyePoint, Inc. and Promis Neurosciences are of similar size ($32.7M and $30.7M). Promis Neurosciences grew revenue faster over the last twelve months: 450.0% against −94.6%. Promis Neurosciences has the higher net margin (0.00% vs −10,998.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Promis Neurosciences leads on 10 and EyePoint, Inc. on 6.

Valuation

Metric EYPT PMN Biotechnology median
P/E n/m n/m 10.60
P/S 11.17 16,913.44 9.40
P/B 0.19 0.75 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.36 0.28 0.66
EV/Sales (41.12) (5,572.97) 9.02
Earnings yield (1,038.89%) (324.53%) (32.88%)
Free cash flow yield (870.23%) (113.16%) (23.13%)

Profitability

Metric EYPT PMN Biotechnology median
Gross margin 41.75% 0.00% 68.51%
Operating margin (11,369.30%) 0.00% 0.00%
Net margin (10,998.67%) 0.00% 0.00%
Free cash flow margin (9,724.68%) 0.00% 0.00%
Return on equity (148.70%) (172.30%) (51.96%)
Return on assets (115.86%) (127.57%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EYPT PMN Biotechnology median
Revenue growth (TTM) (94.63%) 450.00% 6.76%
EPS growth (last fiscal year) (36.64%) (922.18%) 29.88%
Revenue growth, 5-year CAGR (1.85%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EYPT PMN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.50 7.85 4.97
Net debt to EBITDA 1.24 0.15 1.01

Dividend

Metric EYPT PMN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EYPT PMN Biotechnology median
Market cap 30.68m 32.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack